Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.
Goy A, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S, Epner E, Krishnan A, Leonard JP, Lonial S, Nasta S, O'Connor OA, Shi H, Boral AL, Fisher RI. Goy A, et al. Among authors: epner e. Ann Oncol. 2009 Mar;20(3):520-5. doi: 10.1093/annonc/mdn656. Epub 2008 Dec 12. Ann Oncol. 2009. PMID: 19074748 Free PMC article. Clinical Trial.
The epigenetics of mantle cell lymphoma.
Yu M, Epner E. Yu M, et al. Among authors: epner e. Curr Treat Options Oncol. 2007 Oct;8(5):375-81. doi: 10.1007/s11864-007-0047-8. Curr Treat Options Oncol. 2007. PMID: 18214689 Review.
Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Spurgeon SE, Sharma K, Claxton DF, Ehmann C, Pu J, Shimko S, Stewart A, Subbiah N, Palmbach G, LeBlanc F, Latour E, Chen Y, Mori M, Hasanali Z, Epner EM. Spurgeon SE, et al. Among authors: epner em. Br J Haematol. 2019 Sep;186(6):845-854. doi: 10.1111/bjh.16008. Epub 2019 Jun 9. Br J Haematol. 2019. PMID: 31177537 Free article. Clinical Trial.
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
LeBlanc FR, Hasanali ZS, Stuart A, Shimko S, Sharma K, Leshchenko VV, Parekh S, Fu H, Zhang Y, Martin MM, Kester M, Fox T, Liao J, Loughran TP, Evans J, Pu JJ, Spurgeon SE, Aladjem MI, Epner EM. LeBlanc FR, et al. Among authors: epner em. Oncotarget. 2022 Aug 16;13:986-1002. doi: 10.18632/oncotarget.28258. eCollection 2022. Oncotarget. 2022. PMID: 36093297 Free PMC article.
Flipping the cyclin D1 switch in mantle cell lymphoma.
Hasanali Z, Sharma K, Epner E. Hasanali Z, et al. Among authors: epner e. Best Pract Res Clin Haematol. 2012 Jun;25(2):143-52. doi: 10.1016/j.beha.2012.03.001. Epub 2012 May 4. Best Pract Res Clin Haematol. 2012. PMID: 22687450 Review.
Mantle cell lymphoma and its management: where are we now?
Ladha A, Zhao J, Epner EM, Pu JJ. Ladha A, et al. Among authors: epner em. Exp Hematol Oncol. 2019 Jan 30;8:2. doi: 10.1186/s40164-019-0126-0. eCollection 2019. Exp Hematol Oncol. 2019. PMID: 30733891 Free PMC article. Review.
53 results